ArQule Revenue and Competitors
Estimated Revenue & Valuation
- ArQule's total funding is $9.5M.
Employee Data
- 00
ArQule's People
| Name | Title | Email/Phone |
|---|
ArQule Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is ArQule?
ArQule, Inc. is a drug discovery company that engages in drug discovery programs with partners and for its own account under agreements providing for shared and exclusive commercial rights to chemical compounds with therapeutic potential. The Company's key drug discovery products and programs are Compound Discovery Products, Lead Generation/Optimization Programs and Process Redesign Programs.
keywords:N/A
$9.5M
Total Funding
N/A
Number of Employees
N/A
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
ArQule News
2022-04-20 - Non-Small Cell Lung Cancer Drugs Market Size, Scope And ...
... F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Agennix AG, ArQule Inc., GlaxoSmithKline Pharmaceuticals Limited, Daiichi Sankyo Co.
Other Companies in Burlington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 0 | N/A | $10.8M |
#2 | $0.1M | 1 | -67% | N/A |
#3 | $0.1M | 1 | -80% | N/A |
#4 | $0.1M | 1 | N/A | N/A |
#5 | $0.1M | 1 | -50% | N/A |